|
Dhillon, Navneet K; Murphy, William J; Filla, Michael B et al. (2009) Down modulation of IFN-gamma signaling in alveolar macrophages isolated from smokers. Toxicol Appl Pharmacol 237:22-8
|
|
DeHaan, R D; Yazlovitskaya, E M; Persons, D L (2001) Regulation of p53 target gene expression by cisplatin-induced extracellular signal-regulated kinase. Cancer Chemother Pharmacol 48:383-8
|
|
Reese, J; Paria, B C; Brown, N et al. (2000) Coordinated regulation of fetal and maternal prostaglandins directs successful birth and postnatal adaptation in the mouse. Proc Natl Acad Sci U S A 97:9759-64
|
|
Persons, D L; Yazlovitskaya, E M; Pelling, J C (2000) Effect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatin. J Biol Chem 275:35778-85
|
|
Reese, J; Binart, N; Brown, N et al. (2000) Implantation and decidualization defects in prolactin receptor (PRLR)-deficient mice are mediated by ovarian but not uterine PRLR. Endocrinology 141:1872-81
|
|
O'Brien-Ladner, A R; Nelson, S R; Murphy, W J et al. (2000) Iron is a regulatory component of human IL-1beta production. Support for regional variability in the lung. Am J Respir Cell Mol Biol 23:112-9
|
|
Cui, W; Yazlovitskaya, E M; Mayo, M S et al. (2000) Cisplatin-induced response of c-jun N-terminal kinase 1 and extracellular signal--regulated protein kinases 1 and 2 in a series of cisplatin-resistant ovarian carcinoma cell lines. Mol Carcinog 29:219-28
|
|
Yazlovitskaya, E M; Pelling, J C; Persons, D L (1999) Association of apoptosis with the inhibition of extracellular signal-regulated protein kinase activity in the tumor necrosis factor alpha-resistant ovarian carcinoma cell line UCI 101. Mol Carcinog 25:14-20
|
|
Reese, J; Brown, N; Paria, B C et al. (1999) COX-2 compensation in the uterus of COX-1 deficient mice during the pre-implantation period. Mol Cell Endocrinol 150:23-31
|
|
Persons, D L; Yazlovitskaya, E M; Cui, W et al. (1999) Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin. Clin Cancer Res 5:1007-14
|
Showing the most recent 10 out of 14 publications
